B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Belumosudil

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Belumosudil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lx
2 shared targets
y
2 shared targets
gsk
2 shared targets
hydroxyfasudil
2 shared targets
sar
2 shared targets
afuresertib
2 shared targets
ripasudil
2 shared targets
upadacitinib
2 shared targets
fasudil
2 shared targets
uprosertib
2 shared targets
Loading evidence profile...

This evidence profile for Belumosudil is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.